SCHEMBL17107149

SCHEMBL17107149

COc1cc(C(=O)Nc2nc(-c3ccccc3)cs2)cc(OC)c1OC

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 2/20 0.72
HSD17B10 Q99714 2/20 0.72
ALDH1A1 P00352 2/20 0.72
MAPT P10636 2/20 0.72
HPGD P15428 2/20 0.72
TSHR P16473 2/20 0.72
LMNA P02545 2/20 0.72
KDM4E B2RXH2 1/20 0.72
F2 P00734 1/20 0.72
TP53 P04637 1/20 0.72
ALOX15 P16050 1/20 0.72
MAPK1 P28482 1/20 0.72
HTT P42858 1/20 0.72
SMN1; SMN2 Q16637 1/20 0.72
NPSR1 Q6W5P4 1/20 0.72
ADORA3 P0DMS8 1/20 0.69
POLB P06746 1/20 0.61
PARP1 P09874 1/20 0.61
SCD O00767 1/20 0.61
MEN1 O00255 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17107204 0.91 ALDH1A1 (0.66) USP2HSD17B10ALDH1A1MAPTHPGD
SCHEMBL17107224 0.90 SMN1; SMN2 (0.71) USP2HSD17B10ALDH1A1MAPTHPGD
SCHEMBL3338128 0.89 KDM4E (0.68) USP2HSD17B10ALDH1A1MAPTHPGD
SCHEMBL17107236 0.88 ADORA3 (0.73) HSD17B10ALDH1A1MAPTLMNAKDM4E
SCHEMBL18424690 0.86 ADORA3 (0.70) ALDH1A1MAPTHTTADORA3PARP1
SCHEMBL17107107 0.85 MEN1 (0.66) USP2HSD17B10ALDH1A1MAPTHPGD
SCHEMBL17131991 0.83 HPGD (0.62) USP2HSD17B10ALDH1A1MAPTHPGD
SCHEMBL17107130 0.83 MEN1 (0.67) USP2HSD17B10ALDH1A1MAPTHPGD
SCHEMBL16320998 0.83 ADORA3 (0.61) USP2HSD17B10ALDH1A1MAPTTSHR
SCHEMBL12301213 0.83 MAPK1 (0.65) USP2HSD17B10ALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150274714-A1 ANTI-MIGRATION AND ANTI-INVASION THIAZOLE ANALOGS FOR TREATMENT OF CELLULAR PROLIFERATIVE DISEASE XAVIER UNIVERSITY OF LOUISIANA 2015-10-01 US claimed
US-9650369-B2 Anti-migration and anti-invasion thiazole analogs for treatment of cellular proliferative disease XAVIER UNIVERSITY OF LOUISIANA (US) 2017-05-16 US disclosed
US-9650369-B2 Anti-migration and anti-invasion thiazole analogs for treatment of cellular proliferative disease XAVIER UNIVERSITY OF LOUISIANA (US) 2017-05-16 US disclosed
US-9650369-B2 Anti-migration and anti-invasion thiazole analogs for treatment of cellular proliferative disease XAVIER UNIVERSITY OF LOUISIANA (US) 2017-05-16 US disclosed
US-20150274714-A1 ANTI-MIGRATION AND ANTI-INVASION THIAZOLE ANALOGS FOR TREATMENT OF CELLULAR PROLIFERATIVE DISEASE XAVIER UNIVERSITY OF LOUISIANA 2015-10-01 US disclosed
US-20150274714-A1 ANTI-MIGRATION AND ANTI-INVASION THIAZOLE ANALOGS FOR TREATMENT OF CELLULAR PROLIFERATIVE DISEASE XAVIER UNIVERSITY OF LOUISIANA 2015-10-01 US disclosed
US-20150274714-A1 ANTI-MIGRATION AND ANTI-INVASION THIAZOLE ANALOGS FOR TREATMENT OF CELLULAR PROLIFERATIVE DISEASE XAVIER UNIVERSITY OF LOUISIANA 2015-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150274714-A1 ANTI-MIGRATION AND ANTI-INVASION THIAZOLE ANALOGS FOR TREATMENT OF CELLULAR PROLIFERATIVE DISEASE MKI67, MIF, NUDC USP2 4725/4885HSD17B10 1947/4885ALDH1A1 1082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.